Finally, using the public databank BloodSpot (29), the expression of NTAL and its interactors was evaluated in healthy BM HSCs (HSCs; defined by CD34+CD38−CD45RA− cells; n = 6) and blasts from patients with AML (n = 198). This evidence concerns the gene CD34 and acute myeloid leukemia.